市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Tourmaline Bio, Inc. | 看跌 | 混合的 |
AIStockmoo 评分
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | -5.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -1.63 |
|
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 21.93% |
| 机构持股比例 | 90.21% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 48.00 (BMO Capital, 0.36%) | 保留 |
| 48.00 (Piper Sandler, 0.36%) | 保留 | |
| 48.00 (Truist Securities, 0.36%) | 保留 | |
| 48.00 (Guggenheim, 0.36%) | 保留 | |
| 48.00 (Chardan Capital, 0.36%) | 保留 | |
| 48.00 (HC Wainwright & Co., 0.36%) | 保留 | |
| 48.00 (LifeSci Capital, 0.36%) | 保留 | |
| 48.00 (Wedbush, 0.36%) | 保留 | |
| 中 | 48.00 (0.36%) | |
| 低 | 47.50 (Jefferies, -0.69%) | 保留 |
| 平均值 | 47.94 (0.23%) | |
| 总计 | 9 保留 | |
| 平均价格@调整类型 | 47.62 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BMO Capital | 15 Sep 2025 | 48.00 (0.36%) | 保留 | 47.65 |
| Piper Sandler | 11 Sep 2025 | 48.00 (0.36%) | 保留 | 47.60 |
| Chardan Capital | 10 Sep 2025 | 48.00 (0.36%) | 保留 | 47.60 |
| 14 Aug 2025 | 70.00 (46.35%) | 购买 | 22.39 | |
| Guggenheim | 10 Sep 2025 | 48.00 (0.36%) | 保留 | 47.60 |
| 14 Aug 2025 | 55.00 (14.99%) | 购买 | 22.39 | |
| HC Wainwright & Co. | 10 Sep 2025 | 48.00 (0.36%) | 保留 | 47.60 |
| Truist Securities | 10 Sep 2025 | 48.00 (0.36%) | 保留 | 47.60 |
| Jefferies | 09 Sep 2025 | 47.50 (-0.69%) | 保留 | 47.64 |
| LifeSci Capital | 09 Sep 2025 | 48.00 (0.36%) | 保留 | 47.64 |
| Wedbush | 09 Sep 2025 | 48.00 (0.36%) | 保留 | 47.64 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合